Collapsing trachea in dogs and pet insurance: the cough in the chart, the $8,000 stent and the forms that name the disease

A windpipe that flattens: the disease in the surgeons’ words

The ACVS owner page compares the trachea to a vacuum cleaner hose. It is a flexible tube held open by small C-shaped rings of cartilage, with the open part of each C facing upward. In an affected dog the cartilage weakens and flattens, the roof of the trachea stretches, and the airway narrows. The trachea most often collapses at the thoracic inlet, where it bends to enter the chest, and the collapse can run into the mainstem bronchi, the tubes that feed the lungs. ACVS says dogs that are overweight or live with smokers "may be more at risk or at least more likely to show clinical signs," and that there is no known prevention, although reducing weight or exposure to smoke "may help." The Merck Veterinary Manual's owner chapter, last updated September 2024, adds that the cause is unknown and that the condition occurs more often in obese dogs and in those with heart disease or another lung disease, especially chronic bronchitis.

That last point matters for a chart. A cough has more than one explanation, and the workup ACVS describes is built to sort them: bloodwork, chest x-rays that are "useful for ruling out other conditions" and for checking heart size, an echocardiogram to evaluate cardiac function, fluoroscopy (a moving x-ray that shows the airway as the dog breathes in and out) and endoscopy for the best view of the inside of the airway. Ordinary x-rays are not a reliable test for this disease. ACVS says collapse "is not always visible on regular x-rays," and in the Seoul study, where fluoroscopy was the reference, radiographs confirmed roughly 64 percent of cases. A dog can therefore have an x-ray in the file that was read as normal, a cough noted at several visits, and a diagnosis months later. For insurance, the dates that matter are the first sign and the first visit about it, and the diagnosis date is usually the last of them.

Flat-faced breeds have their own airway syndrome, with its own congenital and look-back questions, covered in the brachycephalic airway surgery guide. Imaging is its own line on an invoice, and the clauses that govern it are laid out in the dog MRI and CT cost guide.

Grades 1 to 4 describe the airway, not the invoice

The caption on the ACVS diagram runs the scale from mild, Grade 1 at 25 percent collapse, to severe, Grade 4 at 100 percent, and a later caption describes an endoscopic view of "Grade 2 moderate collapse." The page gives no definition for Grade 3. The Seoul study fills the scale in using the Tangner and Hobson criteria, which grade the maximal narrowing of the lumen on fluoroscopy at 0, 25, 50, 75 and 100 percent.

None of the ten documents mentions a grade, and no source ties a grade to a procedure. ACVS says medical management "may work for up to 70% of dogs, particularly those that have mild collapse," and that as the disease progresses some pets "do not respond to medical management, and require surgical or interventional treatment." The Texas A&M sheet says stenting is "generally reserved for dogs with persistent coughing or difficulty breathing despite diligent medical care." Both sentences hang the next step on how the dog responds. The Seoul researchers found that the location and grade of collapse on fluoroscopy "did not correlate with cough severity" (p = 0.350), and that the grade was mostly related to a high body condition score and low body weight. A Grade 2 dog and a Grade 4 dog can sit on the same treatment step, and the claim follows the step.

For an owner reading a policy, the grade is background. A form pays for a diagnosis, the exams and tests that reached it, and whichever treatment follows, and the treatment depends on how the cough behaves.

Five treatment steps, from a harness to a stent, and who pays at each

The ladder below is arranged by treatment, because the sources order care that way. Only one dollar figure in it comes from a published source: Texas A&M's. Every other figure is an editors' assumption, chosen as a round number to make the arithmetic readable, and none comes from a price list. The Texas A&M sheet states the cost as "$8,000-9,000 for anesthesia, CT and stent placement," adds that pre-operative evaluation "(e.g., labwork, echocardiogram) +/or supportive care (oxygen therapy) may be necessary and will incur additional costs," and gives the stay as 24 hours after the procedure to monitor for coughing. It describes the stent as "a salvage procedure for patients with severe tracheal disease" and puts average survival after stenting at "2-3 years." The file is a 2024 sheet from one teaching hospital service, so a private referral practice may charge differently.

ACVS quotes success rates that put step 4 in proportion. About 70 percent of dogs treated with medical management alone show some improvement, about 75 percent improve after rings, and of dogs that receive stents 95 percent are immediately improved and 90 percent markedly improved at the follow-up visit. In the Seoul study, signs improved in 86.6 percent of cases after weight reduction, environmental changes and drugs, though the study reports that 81 dogs (90.0 percent) still coughed after 2 to 4 weeks of treatment. The path priced in the next section is therefore a stress test for a policy, not a forecast for a dog. A dog that responds to medical management stays on step 2, and for that dog the question is whether a deductible swallows the whole year.

Five years of the same dog, year by year

Now the whole path. Year 1 is the diagnosis and the start of medicines: four exams at $75, chest x-rays at $250, bloodwork at $185, fluoroscopy at a referral center at $900 and twelve months of medicine at $480, which totals $2,115. Year 2 is maintenance, two exams at $75 plus the $480 of medicine, $630. Year 3 adds the $2,200 cough crisis to maintenance, $2,830. Year 4 is the stent at the low end of the range, $8,650. Year 5 adds the $2,400 follow-up to maintenance, $3,030. The five-year total is $17,255. Each design resets its deductible every policy year.

Options 1 and 2 end the five years within $41 of each other, though they get there differently: B reimburses more in every year except the stent year, where its cap costs it $1,520 against A. Option 3, with no ceiling, finishes roughly $3,000 behind both because a 70 percent rate and a $1,000 deductible reset every year. In year 2 it pays nothing at all, since the $630 maintenance bill never clears the deductible. Option 1 pays $104 that year. For the dog that stays on step 2, premiums are the main cost of the policy and a high deductible turns the policy into stent insurance.

Two variations change the totals and a third changes the deductible. If the exam fees in the path are excluded, as they are on the Figo and AKC forms unless a rider is bought, Option 1 pays $11,220 instead of $11,804, which is $584 less. If Option 1's $10,000 limit applies over the dog's lifetime for this condition and not each year, it pays $1,292, $104, $1,864 and $6,520 through year 4, reaches $9,780, and pays only $220 of the year 5 formula amount of $2,024, which leaves the owner $7,255 of the $17,255. And if the dog's insurer reads the later complications as a second condition, a per-condition deductible would be charged again. That last point is why the one-condition wording below gets its own section.

A honk in the chart before the start date

Everything above assumes the first sign came after the policy began. The pre-existing wording is the clause set that decides whether it did, and for this disease the early evidence is oddly ordinary. A dog that coughs when picked up, when the collar is pulled or when excited can have those signs mentioned at a vaccine visit, to a groomer, or in a boarding kennel's notes. ACVS's own sign list includes coughing "when picked up or if someone pulls on their collar," which are things a handler sees without any equipment.

The ten documents define the pre-existing condition in three broad ways. They differ on whose observation counts, on how closely a sign must relate to the claimed condition and on how far back the look runs.

The first difference that matters is who has to have seen the sign. The Spot sample counts a sign "observed by any individual" or one that "would have been detectable by a routine physical veterinary exam," so a groomer's remark and an exam that missed a cough can both be read against the dog. Embrace and Lemonade require "verifiable sources," which is undefined in the policy pages, but which on its face asks for something an insurer can check. The Seoul authors note that tracheal palpation "has limited diagnostic value and may induce paroxysmal coughing in some patients," so what a routine exam would have detected is a question a reviewer could argue either way.

The second difference is how closely the earlier sign must resemble the claim. "Consistent with," in the Nationwide, MetLife and Trupanion wording, is the broader test. A cough is consistent with a collapsing trachea, and it is consistent with the bronchitis and heart disease Merck lists beside it, so on a literal read a cough note can reach the claim whatever it was eventually blamed on. "Directly related," at Embrace and Lemonade, asks for a closer link, and on its words an earlier cough that was diagnosed and treated as something else is easier to keep outside the claim. The third difference is the length of the look-back. Trupanion's 2011 form stops at 18 months. Figo's twelve-month look-back covers illnesses, but its chronic-condition limb has none, and most of the other forms say "prior to" the start date and stop there.

This table reports the reach of the words and nothing about claim practice. A form's text sets the outer edge of what a reviewer may argue, and the practical test is whether the pre-existing question appears in writing before the policy is bought. The pre-existing conditions guide compares the same families of wording for other conditions, and the waiting periods guide shows how each clock is counted. In these samples the illness wait is 5 days at AKC, 14 days at Figo, Spot, Embrace and MetLife and 30 days in the 2011 Trupanion form, and each of those six forms treats an illness that first shows in that window as pre-existing.

Six chart entries against three kinds of wording

The table below takes six things that can sit in a dog's file and runs each through three wordings from the table above: Trupanion's 18-month "evidence and/or symptoms" test, the Nationwide and MetLife "consistent with" test, and the Embrace and Lemonade "directly related" test. The entries are hypothetical, and each cell says only what the text reaches.

The last row is the point the switching guide makes about every move: a new insurer starts its own waiting period and runs its own pre-existing test against the whole chart, and the protection a current policy gives a diagnosed condition on renewal does not travel.

Why a cured clause cannot help an irreversible disease

Several forms let a pre-existing condition back in after a symptom-free stretch. Those routes are written for illnesses that resolve, and ACVS calls tracheal collapse "chronic, progressive, irreversible." Set against that word, most of the routes in the sample set do not open for this disease. The Texas A&M sheet says "On-going medical therapy is necessary to prevent or manage coughing and/or infection" after a stent, and ACVS says medical management "will need to be continued for life, even after other interventions."

AKC's 365-day clause is the outlier in this set. It is the only route in the set that does not ask the condition to have healed. A dog whose cough was noted before enrollment would, on that wording, wait 365 days of continuous coverage before treatment of the condition becomes eligible, and nothing in the clause excludes chronic conditions from it. In the arithmetic above, a form with AKC's route and Option 1's numbers would pay nothing in year 1 and then $104, $1,864, $6,520 and $2,024 in years 2 to 5, a total of $10,512, which leaves the owner $6,743 of the $17,255. Figo's 2023 sample has nothing comparable, and a pre-existing collapse there pays $0 across the same five years. The after-diagnosis guide lists other forms with ways back.

The cure clauses do work in one direction: a cough that was a different, resolved illness. An early kennel cough that cleared for 12 months would be a cured temporary condition on the Lemonade and Figo wording. Whether the insurer then treats it as related to a later collapse is the question the earlier tables raised.

When the form names the disease: Nationwide in 2015 and 2017

Two older Nationwide forms treat collapsed trachea as a category of its own, and they read differently from every other form in the set. The filed form says, dated February 2015, that in the Major Medical Plan benefit schedule (VS-G-3-a 02-15) "Collapsed Trachea-Medical" (code 6101) and "Collapsed Trachea-Surgical" (code 6104) sit among the "Ineligible Conditions," a list of more than 100 diagnoses that includes hip dysplasia, patellar luxation and inherited laryngeal paralysis. The schedule says these are "not covered by your policy, except as specified in section 7." Section 7 of the coverage form (VS-G-3-CA 02-15) then pays "up to $275 during the policy term" for diagnosis or medical treatment, and "up to $550" for surgery. Neither is paid in the first year: the medical allowance is withheld "for any diagnosis or medical treatment provided in the first twelve months that this policy is in effect," and the surgical one "for any surgery that occurs in the first twelve months."

Run the five-year path through that wording. Year 1 pays $0. Years 2, 3 and 5 each pay at most $275, since the cough crisis and the maintenance are medical care. Year 4 pays at most $550 if the stent placement is read as surgery. The ceiling is $0 + $275 + $275 + $550 + $275 = $1,375 of the $17,255, which leaves the owner $15,880. Exclusion V of the same form also removes "any complication or progression of any condition excluded by this policy," and a reviewer could read that against the year 5 follow-up as well.

The 2017 Superior Plan form (VS-21 02-17) goes further. Exclusion H reads, in full, "The following respiratory disorder: (1) Collapsed trachea." No allowance is attached, so the five-year path pays $0. These forms are the strongest reason to ask for the list of excluded or limited conditions before enrolling any small-breed dog. These are 2015 and 2017 editions, and a form that once listed the disease is a reason to ask whether any current rider, declarations page or "Additional Excluded Condition" does so now. The site's hereditary and bilateral exclusions guide explains the three definitions that carve breed conditions out of cover.

The stent, the prosthesis line and other exclusions that could touch it

A stent is a metal device left in the airway, and several forms exclude devices. AKC's exclusion p reads "Experimental, investigational Treatment, organ and tissue transplants or prosthesis," the exclusion r of the PetPartners 2014 terms is nearly identical, and neither form defines prosthesis. Trupanion's policy, dated 2011 in the filed form, excludes "Orthotic devices, prosthetic devices and carts," and its definitions are narrow: a prosthetic device is one "used to replace a missing limb or part of a limb when medically required for mobility," and an orthotic device is an assistive device for "an animal's injured or disabled limb or spine." On those definitions an airway stent is neither. Spot's exclusion g covers "Cosmetic and elective prostheses or procedures," and a stent is neither cosmetic nor elective as ACVS and Texas A&M describe it. Whether a particular insurer reads the AKC and PetPartners word to include a stent is not answered by the text, so it is a question for the insurer in writing.

The experimental-treatment half of that same exclusion deserves the same question. ACVS lists stenting as a treatment and Texas A&M publishes a price range for it, but a form's word "investigational" belongs to the insurer's reading, and the sample forms do not define it.

Three more lines touch the earlier steps. Figo's exclusion 3 and AKC's exclusion c remove physical examination fees unless a rider is bought, and a year of rechecks is mostly exams. Weight is the first thing ACVS lists in medical management, and AKC's exclusion x removes treatment of "being obese or overweight, if not due to an underlying medical condition," while Spot's exclusion t removes prescription pet food "used beyond resolution of symptoms for prevention or general health maintenance (including weight loss)" and Figo's exclusion 17 removes "all foods, whether prescribed or not." Finally, AKC's exclusion y removes "Congenital and Inherited conditions" unless HereditaryPlus is bought. Merck says the cause of tracheal collapse is unknown, and ACVS does not call it hereditary, so the exclusion applies only if the insurer classes the disease that way. That is one more question to put to the insurer for a Pomeranian or a Yorkshire Terrier.

Four written answers settle most of this ahead of time. Does the form, a rider or the declarations page list tracheal collapse, or any alternative name for it, as an excluded or limited condition? Which of the three tests above applies to signs before the start date, who may have observed them and how far back does the look run? Is a tracheal stent a covered surgery, and do the prosthesis and investigational lines reach it? Are a complication and a recurrence one condition with one deductible and one limit? Keep the replies with the policy papers and read them against the form that arrives.

One disease in several places: deductibles, incidents and limits

The disease spreads. ACVS says the collapse can extend into the bronchi, and in the Seoul study bronchial collapse was found in 75 of 110 dogs, 68.1 percent. A stent that irritates the airway, a ring that damages the larynx and a fracture at the thoracic inlet are all consequences of one disease and its treatment. Forms handle that in three ways. Trupanion's 2011 form defines a condition as manifestations of symptoms "regardless of the number of incidents or areas of the body affected," and charges its deductible on "any one condition or injury." Nationwide's 2015 form says "All clinical signs or symptoms of an illness constitute one illness." AKC says that "If an Incident is recurring or chronic, it will be considered one (1) Incident," and its policy limits include per-incident limits as well as an annual limit.

For the owner this cuts both ways. A per-condition deductible is paid once, which helps in years 2 to 5. A per-incident or lifetime limit, as in the Option 1 variation above, counts every year's care against one ceiling, and a stent placed in year 4 can use up what a year 5 complication needs. The reverse also holds on forms that treat a complication as new: a second deductible and possibly a second waiting period. Lemonade's text sets one protective rule, that "A condition for which coverage is afforded on a policy cannot be considered a pre-existing condition on any renewal of the policy." Figo, Embrace and AKC waive their waiting periods at renewal, so a covered collapse stays covered for as long as the policy renews on the same terms. The renewal and age questions behind that are in the senior dog guide.

Five places on the cough timeline, and the paperwork each one still leaves open

Each position is set against the wording above. The advice concerns paperwork and timing, and says nothing about what a dog should receive.

Older at enrollment, and premiums at scale

Most dogs in the Seoul study were diagnosed late: 101 of 110 were older than 8. For a dog enrolled as a puppy the waiting period is almost irrelevant to this disease, and the risk is the chart. For a dog adopted at 7 or 9 the waiting period and the look-back are both live, and the age cutoffs for enrollment matter as well, as the age limits guide explains.

The site's breed pages publish monthly premium anchors for three of the four breeds ACVS names: Yorkshire Terrier $41, Pomeranian $43 and Chihuahua $33 per month, each a published anchor, not a quote (MoneyGeek pet insurance cost analysis, 2026 middle-aged dogs, monthly average, reviewed October 4, 2026). Embrace's disclosure says a premium "could result in a possible increase based on your claim history, the age of the covered Pet or if you change your geographic location." Multiplied by 60 months the anchors come to $2,460, $2,580 and $1,980, which is a scale to hold against the stress path, not a prediction of any dog's premium. On the quiet step-2 year, the maintenance bill of $630 exceeds a year of premium at the Yorkshire Terrier anchor, $492, by only $138, and Option 1 returns $104 of it. On the stent year it returns $6,520. The insurance versus savings guide weighs a premium against a savings fund in general, and the CalculatorVillage calculators do the generic sums.

The other chronic-disease guides in the conditions hub raise the same limit questions, and the anchors above are published samples, not quotes: get a live quote before deciding.